Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: consultee and commentator comments on the ACD
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Novartis comments
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Cystic Fibrosis Trust comments
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Chartered Society of Physiotherapy comments
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Royal College of Nursing comments
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Royal College of Paediatrics and Child Health comments
Cystic fibrosis (pseudomonas lung infection) - colistimethate sodium and tobramycin: Healthcare Improvement Scotland comments
This page was last updated: 23 January 2013